AlphaCore Capital
ROIV icon

AlphaCore Capital’s Roivant Sciences ROIV Stock Holding History

AlphaCore Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$365K Buy
+9,979
New +$362K 0.01% 985

Other funds holding ROIV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Penn Davis McFarland
Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return

AlphaCore Capital's ROIV Position: Q3 2026 in Review

AlphaCore Capital opened a new position in Roivant Sciences (ROIV) in Q3 2026: 9,979 shares worth $365K. The stake represents 0.01% of the portfolio and ranks #985 among its holdings.

215 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • AlphaCore Capital held 9,979 shares of Roivant Sciences worth $365K as of Q3 2026.
  • Roivant Sciences was a new AlphaCore Capital position in Q3 2026.
  • Roivant Sciences made up 0.01% of AlphaCore Capital's portfolio in Q3 2026, its #985 holding.
  • 215 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on AlphaCore Capital's 13F filing for Q3 2026, filed 4 Nov 2026.